Barrow Hanley Mewhinney & Strauss LLC decreased its position in SunOpta Inc. (NASDAQ:STKL - Free Report) TSE: SOY by 4.1% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 4,832,764 shares of the company's stock after selling 204,341 shares during the period. Barrow Hanley Mewhinney & Strauss LLC owned about 4.04% of SunOpta worth $37,212,000 at the end of the most recent quarter.
A number of other large investors have also modified their holdings of STKL. D.A. Davidson & CO. acquired a new stake in shares of SunOpta during the 4th quarter valued at about $81,000. Mutual Advisors LLC acquired a new stake in SunOpta in the fourth quarter valued at approximately $92,000. EP Wealth Advisors LLC purchased a new stake in shares of SunOpta in the third quarter valued at approximately $79,000. Paloma Partners Management Co acquired a new position in shares of SunOpta during the 3rd quarter worth approximately $85,000. Finally, Quantinno Capital Management LP raised its stake in shares of SunOpta by 33.1% during the 3rd quarter. Quantinno Capital Management LP now owns 13,522 shares of the company's stock worth $86,000 after buying an additional 3,360 shares during the period. Institutional investors and hedge funds own 85.39% of the company's stock.
SunOpta Price Performance
Shares of NASDAQ:STKL traded up $0.01 during trading on Wednesday, reaching $4.71. The stock had a trading volume of 1,003,776 shares, compared to its average volume of 741,388. The business has a fifty day moving average price of $6.45 and a 200-day moving average price of $6.87. SunOpta Inc. has a 1-year low of $4.57 and a 1-year high of $8.11. The company has a debt-to-equity ratio of 1.61, a quick ratio of 0.53 and a current ratio of 1.20. The stock has a market cap of $564.05 million, a PE ratio of -26.17 and a beta of 1.90.
SunOpta (NASDAQ:STKL - Get Free Report) TSE: SOY last released its earnings results on Wednesday, February 26th. The company reported $0.06 earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of $0.06. The business had revenue of $193.91 million during the quarter, compared to analyst estimates of $189.90 million. SunOpta had a negative net margin of 2.74% and a positive return on equity of 7.92%. On average, equities analysts forecast that SunOpta Inc. will post 0.13 earnings per share for the current fiscal year.
Analyst Upgrades and Downgrades
Several equities research analysts recently commented on the stock. StockNews.com raised shares of SunOpta from a "sell" rating to a "hold" rating in a report on Tuesday, March 11th. Stephens reissued an "overweight" rating and set a $10.00 target price on shares of SunOpta in a research note on Thursday, January 2nd.
Read Our Latest Stock Report on STKL
Insiders Place Their Bets
In related news, SVP Bryan P. Clark sold 8,500 shares of the stock in a transaction that occurred on Thursday, March 13th. The stock was sold at an average price of $5.32, for a total value of $45,220.00. Following the completion of the sale, the senior vice president now owns 28,150 shares of the company's stock, valued at approximately $149,758. This trade represents a 23.19 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Corporate insiders own 6.48% of the company's stock.
SunOpta Profile
(
Free Report)
SunOpta Inc engages in manufacture and sale of plant-based and fruit-based food and beverage products in the United States, Canada, and internationally. The company provides plant-based beverages utilizing oat, almond, soy, coconut, rice, hemp, and other bases under the Dream and West Life brands; oat-based creamers under the SOWN brand; ready-to-drink protein shakes; and nut, grain, seed, and legume based beverages; packaged teas and concentrates; and meat and vegetable broths and stocks.
Recommended Stories

Before you consider SunOpta, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and SunOpta wasn't on the list.
While SunOpta currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.